Je was op zoek naar: cytopenia (Engels - Deens)

antibody cytopenia
antistof-cytopeni

neutro-cytopenia
neutropeni

if cytopenia persists for
hvis cytopeni vedvarer i 2 uger, reducér dosis yderligere til 200 mg/m2.

anaemia, thrombo- cytopenia
anæmi, trombo- cytopeni

if recurrence of cytopenia, repeat step 1
hvis cytopeni recidiverer, gentages trin

1.check whether cytopenia is related to
undersøg om cytopeni er relateret til leukæmi (marv-aspirat eller biopsi).

neutropenia, leukopenia, anaemia, thrombo- cytopenia
neutropeni, leukopeni, anæmi, , trombocytope ni

febrile neutropenia, thrombo- cytopenia, anaemia, leukopenia
febril neutropeni, trombocytopeni, anæmi, leukopeni

jakavi dose can be titrated to reduce the risk of cytopenia.
jakavi-doseringen kan titreres for at reducere risikoen for cytopeni.

if cytopenia persists for 2weeks, reduce further to 300 mg.
hvis cytopeni vedvarer i 2 uger, reducér dosis yderligere til 300 mg.

if cytopenia persists for 2weeks, reduce further to 200mg/m2.
hvis cytopeni vedvarer i 2 uger, reducér dosis yderligere til 200 mg/m2.

interruption of treatment should be considered in patients who develop unexplained cytopenia.
hos patienter, der udvikler uforklarlig cytopeni, bør det vurderes, om behandlingen skal afbrydes.

check if cytopenia is related to leukaemia (marrow aspirate or biopsy).
1 undersøg om cytopeni er relateret til leukæmi (marvaspirat eller biopsi).

check whether cytopenia is related to leukaemia (marrow aspirate or biopsy).
undersøg om cytopeni er relateret til leukæmi (marv-aspirat eller biopsi).

therefore all patients experienced profound cytopenia: leukopenia 96%, thrombocytopenia 94%, and anemia 88%.
derfor fik alle patienter omfattende cytopeni: leukopeni 96%, trombocytopeni 94% og anæmi 88%.

in cml, cytopenias (thrombocytopenia, neutropenia, and anaemia) were a consistent finding.
ved cml var cytopenier (trombocytopeni, neutropeni og anæmi) vedvarende fund.